NL7204972A - - Google Patents

Info

Publication number
NL7204972A
NL7204972A NL7204972A NL7204972A NL7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A NL 7204972 A NL7204972 A NL 7204972A
Authority
NL
Netherlands
Application number
NL7204972A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7204972A publication Critical patent/NL7204972A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D235/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62Benzothiazoles
    • C07D277/64Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL7204972A 1971-04-21 1972-04-13 NL7204972A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (1)

Publication Number Publication Date
NL7204972A true NL7204972A (en) 1972-10-24

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7204972A NL7204972A (en) 1971-04-21 1972-04-13

Country Status (4)

Country Link
DE (1) DE2219408A1 (en)
FR (1) FR2133979B1 (en)
GB (1) GB1356763A (en)
NL (1) NL7204972A (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
CA2566609C (en) 2004-05-13 2012-06-26 Icos Corporation Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
NZ611764A (en) 2008-11-13 2015-01-30 Gilead Calistoga Llc Therapies for hematologic malignancies
EA019499B1 (en) 2009-03-24 2014-04-30 ГИЛИЭД КАЛИСТОГА ЭлЭлСи Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
SG175259A1 (en) 2009-04-20 2011-11-28 Gilead Calistoga Llc Methods of treatment for solid tumors
WO2011011550A1 (en) 2009-07-21 2011-01-27 Calistoga Pharmaceuticals Inc. Treatment of liver disorders with pi3k inhibitors
NZ603789A (en) * 2010-05-26 2015-03-27 Sunovion Pharmaceuticals Inc Heteroaryl compounds and methods of use thereof
US8765760B2 (en) * 2011-01-11 2014-07-01 Sunovion Pharmaceuticals, Inc. [1,2,4] triazol [1,5-a] pyrazines useful as inhibitors of phosphodiesterases
WO2013134288A1 (en) 2012-03-05 2013-09-12 Gilead Calistoga Llc Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
JP2017500319A (en) 2013-12-20 2017-01-05 ギリアード カリストガ エルエルシー Polymorphic form of the hydrochloride salt of (S) -2- (1- (9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
JP2017502021A (en) 2013-12-20 2017-01-19 ギリアード カリストガ エルエルシー Process method for phosphatidylinositol 3-kinase inhibitors
CA2952012A1 (en) 2014-06-13 2015-12-17 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors
CN111944340B (en) * 2020-08-21 2022-08-05 无锡市乐卡新材料有限公司 Salt-fog-resistant antirust coating

Also Published As

Publication number Publication date
FR2133979A1 (en) 1972-12-01
FR2133979B1 (en) 1975-10-31
GB1356763A (en) 1974-06-12
DE2219408A1 (en) 1972-10-26

Similar Documents

Publication Publication Date Title
FR2133979B1 (en)
ATA136472A (en)
AR196074A1 (en)
AU2658571A (en)
AU2691671A (en)
AU2485671A (en)
AU2742671A (en)
AU2684071A (en)
AU2564071A (en)
AU2654071A (en)
AU2684171A (en)
AU2456871A (en)
AU2473671A (en)
AU2755871A (en)
AU2415871A (en)
AU2486471A (en)
AU3025871A (en)
AU2503871A (en)
AU2740271A (en)
AU2577671A (en)
AU2588771A (en)
AU2399971A (en)
AU3038671A (en)
AU1109576A (en)
AU2726271A (en)